Trevena : Reports Fourth Quarter 2023 Results and Provides Corporate Update - Form 8-K -April 01, 2024 at 06:12 am EDT
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important...